CSIMarket
 


Compugen Ltd  (CGEN)
Other Ticker:  
 
 

Compugen Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Compugen Ltd asset turnover ratio, the ability of Compugen Ltd's assets to generate revenue in the forth quarter 2022, increased sequentially to 0.08 in the fourth quarter (Dec 31 2022), yet the ratio remained below the average, as CGEN's position remain challenging.

Within sector 59 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Forth Quarter 2022 compared to the preceding quarter from 0 to 4001.


What is Asset Turnover Ratio?
What is Compugen Ltd Market Share?


CGEN Asset Turnover Ratio (Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Asset Change -28.74 % -28.74 % -28.74 % -28.74 % -4.45 %
Y / Y Revenue Change 25 % - - - 200 %
Asset Turnover Ratio (TTM) 0.08 - - - 0.05
CGEN's Total Ranking # 4001 # 0 # 3812 # 3981 # 3864
Seq. Asset Change 0 % 0 % 0 % -28.74 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 60
Healthcare Sector # 614
Overall Market # 4001

Asset Turnover Ratio Statistics
High Average Low
0.22 0.08 0.01
(Jun 30 2018)   (Dec 31 2020)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Regen Biopharma Inc  0.22 $ 0.126  Millions$ 0.573  Millions
Fortress Biotech Inc   0.22 $ 75.743  Millions$ 347.437  Millions
Adaptive Biotechnologies Corporation  0.22 $ 185.308  Millions$ 851.413  Millions
Voyager Therapeutics Inc   0.22 $ 40.907  Millions$ 188.656  Millions
Dariohealth Corp   0.22 $ 27.656  Millions$ 127.549  Millions
Enanta Pharmaceuticals Inc  0.22 $ 82.097  Millions$ 378.744  Millions
Bio rad Laboratories Inc   0.21 $ 2,802.249  Millions$ 13,153.988  Millions
Revance Therapeutics Inc   0.21 $ 132.565  Millions$ 623.730  Millions
Fibrogen Inc   0.21 $ 140.734  Millions$ 662.912  Millions
Affimed N v   0.21 $ 46.315  Millions$ 224.573  Millions
Evoke Pharma Inc   0.21 $ 2.509  Millions$ 12.173  Millions
Cytomx Therapeutics Inc   0.20 $ 53.163  Millions$ 261.074  Millions
Insmed Inc  0.20 $ 243.832  Millions$ 1,214.480  Millions
Beigene ltd   0.20 $ 1,415.921  Millions$ 7,126.225  Millions
Cara Therapeutics inc   0.20 $ 41.867  Millions$ 211.546  Millions
Marker Therapeutics inc   0.20 $ 9.014  Millions$ 45.703  Millions
Theralink Technologies Inc   0.20 $ 0.544  Millions$ 2.761  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 196.245  Millions$ 998.686  Millions
Gelesis Holdings Inc   0.20 $ 25.767  Millions$ 131.422  Millions
Chimerix Inc   0.20 $ 33.824  Millions$ 173.075  Millions
Sophia Genetics Sa  0.20 $ 47.560  Millions$ 243.838  Millions
Tivic Health Systems Inc   0.19 $ 1.840  Millions$ 9.446  Millions
Clever Leaves Holdings Inc   0.19 $ 17.800  Millions$ 91.548  Millions
Xencor Inc  0.19 $ 164.579  Millions$ 847.696  Millions
Veru Inc   0.19 $ 27.727  Millions$ 143.328  Millions
Personalis Inc   0.19 $ 65.047  Millions$ 337.297  Millions
Nutriband Inc   0.19 $ 2.080  Millions$ 10.874  Millions
Accelerate Diagnostics Inc   0.19 $ 12.752  Millions$ 67.486  Millions
Eyepoint Pharmaceuticals Inc   0.19 $ 41.404  Millions$ 219.709  Millions
Invitae Corporation  0.19 $ 516.303  Millions$ 2,759.666  Millions

Date modified: 2023-04-03T20:59:23+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com